Two doses of the widely used HPV vaccine Gardasil9 produced an immune response identical to the standard three-dose regimen in women with well-controlled HIV, according to a study by Dr Deborah ...

A pilot study in north London in which a network of GP practices proactively contacted their patients to suggest statins found higher takeup levels. This was one of several studies at BHIVA to find ...

📢 With heavy hearts, we announce the proposed closure of our beloved charity, NAM aidsmap, this month. After 37 years of pioneering health journalism, community engagement, and empowerment through ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...

A CRISPR-based gene-editing therapy called EBT-101 was safe and well tolerated but did not prevent viral rebound in three participants who stopped antiretroviral treatment in an early study, according ...

Research suggests these RT enzymes may be still able to introduce random genetic recombinations and amplifications (increasing the copy number of certain harmful genes) in the brain cells causing them ...

A longer-acting formulation of cabotegravir may offer an HIV pre-exposure prophylaxis (PrEP) and treatment option that could be administered once every four months, according to early study results ...

A programme in rural Kenya and Uganda that has already demonstrated that a dynamic, person-centred HIV prevention intervention results in substantial increases in the numbers of people covered by PrEP ...

The San Francisco Department of Public Health (SF DPH) was ahead of the game, issuing doxyPEP recommendations a year earlier and getting a head start on compiling real-world data. San Francisco’s ...

BHIVA recommends that people aged 40 and over should be offered a statin irrespective of lipid levels or estimated cardiovascular risk. People with HIV aged 40 and over with an estimated 10-year risk ...

An HIV vaccine candidate has proved it can guide B-cells, the part of the immune system that makes antibodies, into being able to produce broadly neutralising antibodies (bnAbs) with the ability to ...

Key populations are also key to the HIV response in Thailand. Many clinics and services are led and staffed by members of the community that they serve. Almost half (47%) of new HIV diagnoses among ...